Publications

CAR-T

Publications

Follicle-stimulating Hormone Receptor is Expressed by Most Ovarian Cancer Subtypes and is a Safe and Effective Immunotherapeutic Target

Breast Cancer Vaccine

Publications

Targeted Vaccination against Human α-Lactalbumin for Immunotherapy and Primary Immunoprevention of Triple Negative Breast Cancer

Cchek^TM

Posters

Combining MDSC immunophenotyping with the HyperVOX computational technique: a usable input into pattern recognition neural networks for early detection of stage I/II breast cancer (BCa)

Combining MDSC immunophenotyping with the HyperVOX computational technique: a usable input into pattern recognition neural networks for early detection of stage I/II breast cancer (BCa)

Combining Machine Learning (ML) with Flow Cytometry Based Immunophenotyping: a Novel Liquid Biopsy Aid for Identifying the Risk for Prostate Cancer (PCa)

Combining Machine Learning (ML) with Flow Cytometry Based Immunophenotyping: a Novel Liquid Biopsy Aid for Identifying the Risk for Prostate Cancer (PCa)

Latest News & Events

Nov 20, 2019

Anixa Biosciences Announces Collaboration with Idaho Urologic Institute on Cchek™ Prostate Cancer Study

Read More...

Nov 7, 2019

Anixa Biosciences Announces Presentation at Cell Symposia: Hallmarks of Cancer

Read More...

Nov 5, 2019

Anixa Biosciences Announces Patent Issued for its Breast Cancer Vaccine

Read More...

Cancer Fact: Liver cancer accounts for 3.6% of worldwide cancer incidences.